|
| |
Leukemia Myeloid Chronic-PhaseDownload PDF containing detailed information.
Recent Publications on Leukemia Myeloid Chronic-Phase: |  |
Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report.
We report a case of chronic myeloid leukemia in chronic stage with 48... | 13th November, 2009
| Division of Genetics, Department of Pathology, V. Macarena University
| Cancer Genet Cytogenet. 2009 Nov;195(1):71-4.
DOI Direct Link |
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.
Ph-positive chronic myeloid leukemia (CML) and Ph-negative chronic... | 6th November, 2009
| Department of Haematology, Imperial College at Hammersmith Hospital,
| Leukemia. 2009 Oct;23(10):1708-15. Epub 2009 Jul 30.
DOI Direct Link |
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patients.
BACKGROUND: Nilotinib, an oral second-generation Bcr-Abi tyrosine kinase... | 29th October, 2009
| Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine,
| Clin Ther. 2009 Jul;31(7):1568-75.
DOI Direct Link |
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses.
PURPOSE: Long-term clinical outcome data have established imatinib 400... | 27th October, 2009
| The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030,
| J Clin Oncol. 2009 Oct 1;27(28):4754-9. Epub 2009 Aug 31.
DOI Direct Link |
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
BACKGROUND: In patients with chronic-phase chronic myeloid leukemia... | 9th October, 2009
| Department of Leukemia, The University of Texas M. D. Anderson Cancer
| Cancer. 2009 Sep 15;115(18):4136-47.
DOI Direct Link |
→View more research publications. |
Press Releases About Leukemia Myeloid Chronic-Phase:
|
 |
| Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting |
24th November, 2009 |
Ambit Biosciences Corporation |
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
|
| PROLOR Biotech Reports Merck Receives Positive Regulatory Opinion for European Marketing of Long-Acting CTP-Modified Fertility Treatment ELONVA(R) (FSH-CTP) |
24th November, 2009 |
PROLOR Biotech, Inc. |
NES-ZIONA, Israel, Nov. 24 /PRNewswire/ -- PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the
|
| NeurogesX to Present at Piper Jaffray Health Care Conference |
24th November, 2009 |
NeurogesX, Inc. |
SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced
|
| NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director |
24th November, 2009 |
NeurogesX, Inc. |
SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today
|
| Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference |
24th November, 2009 |
Keryx Biopharmaceuticals, Inc. |
NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the
|
BioPortfolio Ltd. offers e-mail and postal lists for Leukemia Myeloid Chronic-Phase scientists - we have details of around 43 individuals working on Leukemia Myeloid Chronic-Phase .
This page has been viewed 296 times
Recent Search Terms used to find this page: chronic phase leukemia | chronic phase | leukemia myeloid chronic pcr | chronic myelod leukema | chronic myelod leukema | chronic myelod leukema | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Leukemia Myeloid Chronic-Phase across BioPortfolio, or for Leukemia Myeloid Chronic-Phase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
